AMY VANDER VORSTE: Open Payments
NPI 1952929366 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 79 payments from 15 companies in 2025. Trend: 2023 $649 · 2024 $1,127 · 2025 $1,056
Food & beverage: $1,056
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $241 |
| Corcept Therapeutics | 5 | $196 |
| ABBVIE INC. | 20 | $151 |
| PFIZER INC. | 16 | $142 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Lundbeck LLC | 2 | $51 |
| Astellas Pharma US Inc | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Bioventus LLC | 1 | $26 |
Products named: Korlym, NURTEC ODT, UBRELVY, Wegovy, Ozempic, Symbravo, VYEPTI, Veozah.
Industry payments across TX — which companies pay providers there.
